Phase 1 Lymph Node Metastases Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases

Lymph Node MetastasesUnresectable Pancreatic CancerAdvanced Pancreatic Cancer

Chengdu New Radiomedicine Technology Co. LTD.58 enrolled6 locationsNCT06278454

Completed

Phase 1

To determine whether use of Technetium99m-labelled PSMA improves the sensitivity for detection and aids intra-operative localisation of lymph node metastases in men with intermediate or high-risk localised prostate cancer undergoing robotic-assisted radical prostatectomy.

Prostate Cancer with lymph node metastases

St. Vincent's Prostate Cancer Research Centre20 enrolled1 locationACTRN12621001728820